Novartis strikes deal with UK biotech for up to US$1.7 billion
Novartis is on a deal spree this year, including the US$12 billion acquisition of Avidity Biosciences Novartis will pay UK biotech…
Tag
Novartis is on a deal spree this year, including the US$12 billion acquisition of Avidity Biosciences Novartis will pay UK biotech…
Mainland retail traders are being lured by the outperformance of the city’s equities Hot themes from artificial intelligence (AI) to…
Higher revenue is driven by increased contributions from its early detection and precision multi-omics segment Local biotech startup…
Six times stronger than Vitamin C. Four times more potent than Vitamin E. And clean enough to spray near your eyes. Meet the mist that’s…
China’s biotechnology stocks have shaken off a four-year slump to be among the hottest performers in Asia this year and funds are tipping…
K has held talks to buy Swiss biotech MoonLake Immunotherapeutics for more than US$3 billion, the Financial Times reported on Monday,…
High-growth companies in the technology, healthcare and sustainability-linked industries are potential entrants, too MARKET watchers…
High-growth companies in the technology, healthcare and sustainability-linked industries are potential entrants, too MARKET watchers…
GSK agreed to buy US biotech IDRx for as much as US$1.15 billion to gain new cancer medicines. The UK drugmaker will pay US$1 billion…
JOHNSON & Johnson (J&J) is in talks to acquire Intra-Cellular Therapies, a biopharmaceutical company focused on treatments for central…
AT A time when geopolitical tensions are hitting industries from semiconductors to electric vehicles, pharmaceutical dealmaking has become…